400 related articles for article (PubMed ID: 18055180)
1. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
Modestin J; Wehrli MV; Stephan PL; Agarwalla P
Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
[TBL] [Abstract][Full Text] [Related]
2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
3. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
4. Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.
Muscettola G; Barbato G; Pampallona S; Casiello M; Bollini P
J Clin Psychopharmacol; 1999 Jun; 19(3):203-8. PubMed ID: 10350026
[TBL] [Abstract][Full Text] [Related]
5. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
Miller CH; Mohr F; Umbricht D; Woerner M; Fleischhacker WW; Lieberman JA
J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of akathisia in patients receiving stable doses of clozapine.
Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
[TBL] [Abstract][Full Text] [Related]
8. Motor and mental side effects of clozapine.
Gerlach J; Peacock L
J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia.
Modestin J; Stephan PL; Erni T; Umari T
Schizophr Res; 2000 May; 42(3):223-30. PubMed ID: 10785580
[TBL] [Abstract][Full Text] [Related]
10. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
Sachdev P
Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
[TBL] [Abstract][Full Text] [Related]
11. Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.
Peacock L; Solgaard T; Lublin H; Gerlach J
Psychopharmacology (Berl); 1996 Mar; 124(1-2):188-96. PubMed ID: 8935815
[TBL] [Abstract][Full Text] [Related]
12. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
[TBL] [Abstract][Full Text] [Related]
14. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of extrapyramidal effects by neuroleptics in admitted people with schizophrenia].
Moreno-Calvete MC
Enferm Clin; 2013; 23(3):114-7. PubMed ID: 23755945
[TBL] [Abstract][Full Text] [Related]
16. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Tarsy D; Baldessarini RJ
Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
[TBL] [Abstract][Full Text] [Related]
18. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
19. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
20. Effects of newer antipsychotics on extrapyramidal function.
Tarsy D; Baldessarini RJ; Tarazi FI
CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
